Sanders Capital’s HCA Healthcare HCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.25B | Sell |
11,102,583
-462,564
| -4% | -$177M | 5.71% | 5 |
|
|
2025
Q1 | $4B | Sell |
11,565,147
-90,416
| -0.8% | -$31.2M | 5.97% | 5 |
|
|
2024
Q4 | $3.5B | Buy |
11,655,563
+116,826
| +1% | +$35.1M | 5.12% | 6 |
|
|
2024
Q3 | $4.69B | Buy |
11,538,737
+18,175
| +0.2% | +$7.39M | 6.79% | 5 |
|
|
2024
Q2 | $3.7B | Buy |
11,520,562
+83,557
| +0.7% | +$26.8M | 5.67% | 6 |
|
|
2024
Q1 | $3.81B | Buy |
11,437,005
+33,002
| +0.3% | +$11M | 6.37% | 5 |
|
|
2023
Q4 | $3.09B | Buy |
11,404,003
+456,738
| +4% | +$124M | 5.71% | 6 |
|
|
2023
Q3 | $2.69B | Buy |
10,947,265
+7,598
| +0.1% | +$1.87M | 5.69% | 7 |
|
|
2023
Q2 | $3.32B | Buy |
10,939,667
+354,323
| +3% | +$108M | 6.94% | 6 |
|
|
2023
Q1 | $2.79B | Sell |
10,585,344
-154,207
| -1% | -$40.7M | 6.61% | 4 |
|
|
2022
Q4 | $2.58B | Sell |
10,739,551
-385,192
| -3% | -$92.4M | 6.76% | 4 |
|
|
2022
Q3 | $2.04B | Buy |
11,124,743
+4,253
| +0% | +$782K | 5.62% | 7 |
|
|
2022
Q2 | $1.87B | Buy |
11,120,490
+1,374,130
| +14% | +$231M | 4.73% | 9 |
|
|
2022
Q1 | $2.44B | Buy |
9,746,360
+298,323
| +3% | +$74.8M | 5.31% | 7 |
|
|
2021
Q4 | $2.43B | Buy |
9,448,037
+1,365,582
| +17% | +$351M | 4.95% | 8 |
|
|
2021
Q3 | $1.96B | Buy |
8,082,455
+20,334
| +0.3% | +$4.94M | 4.45% | 8 |
|
|
2021
Q2 | $1.67B | Buy |
8,062,121
+266,566
| +3% | +$55.1M | 3.78% | 8 |
|
|
2021
Q1 | $1.47B | Buy |
7,795,555
+121,700
| +2% | +$22.9M | 3.54% | 12 |
|
|
2020
Q4 | $1.26B | Buy |
7,673,855
+540,322
| +8% | +$88.9M | 3.33% | 12 |
|
|
2020
Q3 | $889M | Buy |
7,133,533
+259,582
| +4% | +$32.4M | 3.05% | 13 |
|
|
2020
Q2 | $667M | Buy |
+6,873,951
| New | +$667M | 2.49% | 17 |
|
|
2016
Q2 | – | Sell |
-109,400
| Closed | -$8.54M | – | 48 |
|
|
2016
Q1 | $8.54M | Buy |
+109,400
| New | +$8.54M | 0.07% | 42 |
|